Key Takeaways
- Volume up 19%, revenue down 6%: Raw material price softening passed through to selling prices, masking healthy underlying demand in the core HPPC segment.
- Margins hit a 14.1% floor, with a floor under them: EBITDA margin improved 80 bps YoY as the company prioritized filling capacity over chasing margin, a strategy it says will lift margins further as volumes load fixed costs.
- Two bolt-on integrations are nearly done: Tristar is now 100% owned and Unitop’s remaining stake acquisition is nearing completion, removing minority discounts and simplifying the consolidated story.
- The export engine is idling, not broken: Exports held flat QoQ at ₹80 crore despite deliberate pullback from high-risk geographies and a global textile slowdown; management expects a pickup once destocking ends.
- What to watch next quarter: Whether Unitop’s 2,000-tonne order book converts into reported revenue, the trajectory of recently-upticked raw material prices, and any sign that export demand is troughing.
Volume Versus Price: The Quarter’s Tension
- The headline miss is a price story, not a demand story: Consolidated revenue fell 6% YoY to ₹410.6 crore while volumes grew ~20%, because softening raw material costs were passed through to customers as lower selling prices.
- HPPC carried the volume load: The segment posted 19% YoY volume growth, offset by price corrections that produced a small revenue decline.
- TSC felt the inventory cycle: Steady but muted growth reflected significant destocking by global customers, not lost share.
- AHN is seasonally soft, not structurally weak: The QoQ decline is normal for poultry’s first 4-5 months; management expects a pickup through the year.
- SAP migration clipped April: A planned one-week shutdown plus a stabilization week reduced dispatches, particularly at Unitop, which lost 8-10 selling days.
Menezes: "If you see the HPPC volumes, we have almost a 19% increase in volumes year on year, which overall is a very healthy trend for us. In the ARD also, we have a very healthy volume increase. It was only because of the price correction that happened that you see a small decrease in the HPPC sales."
Margin Strategy: Fill First, Then Lift
- EBITDA margin improved to 14.1%: Up 70 bps QoQ and 80 bps YoY, driven by a mix shift toward higher-margin products, tight cost control, and operating leverage on higher volumes.
- The explicit strategy is volume-led margin expansion: Management is not chasing very high margin growth; it wants to keep margins stable while filling capacity, so that fixed-cost absorption naturally boosts EBITDA.
- New products will carry the margin ambition: Morpholine-based derivatives and aquaculture solutions are being developed for healthy margins, not volume growth, while HPPC remains the engine for filling capacity.
- Depreciation fell QoQ, helping optically: Q1 depreciation of ₹14 crore versus ₹16 crore in Q4 FY23, because Q4 included accelerated depreciation on older Silvassa and Dahej assets under the WDV method.
Menezes: "Our strategy is to fill our capacity; therefore, we are not looking at very high growth in margins. But we would like to keep the margins stable but fill capacity and therefore cost will come down and help us boost our EBITDA margins."
Subsidiary Integration: Tristar and Unitop
- Tristar is now wholly owned: The remaining 16% stake was acquired for ₹16.9 crore, taking ownership to 100% and removing a minority interest drag.
- Unitop is nearly there: Acquisition of the remaining stake is nearing completion, which will also take it to 100%.
- Unitop’s order book signals a strong quarter ahead: Pending orders exceed 2,000 tonnes and capacity utilization is running at 85-90%+, though the SAP shutdown temporarily disrupted dispatches.
- Tristar had a soft April-May but June recovered: Management is not worried and expects good annualized numbers through the year.
- Buzil Rossari’s reported decline is a classification shift: FY23 revenue dropped from ₹85 crore to ₹79 crore because ₹20-25 crore of government tender business was routed through Rossari (not BRPL) to meet tender conditions on net worth and minimum sales.
Exports: Cautious Now, Constructive Later
- Exports flat at ₹80 crore: Same as Q4 FY23, down from ~₹85 crore in Q1 FY23, held back by a global textile slowdown and deliberate caution toward countries with forex or payment risks like Bangladesh and Egypt.
- The next two quarters are expected to stay sluggish: Management hopes to maintain the current run rate, then sees export turnover growing once inventory destocking in textiles ends.
- No long-term raw material bets are being placed: The company does not take very long-term positions on raw materials, positioning itself to handle pricing whichever way it moves, which limits both upside and downside from RM swings.
New Product Pipeline: Morpholine and Beyond
- Four morpholine-based derivatives developed: NMMO, HEM, N-formyl morpholine, and N-methyl morpholine have emerged from the R&D pipeline, with NMMO already approved by major multinationals and a local lyocell manufacturer in India.
- HEM opens a pharma door: Hydroxyethyl morpholine is an intermediate used in drugs for kidney transplants and heart diseases, diversifying the end-market exposure beyond textiles and chemicals.
- Aquaculture solutions are being built as a platform: R&D is designing probiotics, feed additives, disinfectants, and pond management solutions for farmers, targeting a smart-aquaculture value proposition.
- Indian Railways institutional chemicals: Significant progress reported on solutions tailored to the railways’ needs, though no revenue or timeline was quantified.
- New products are margin-first, not volume-first: Management explicitly stated it will not chase volumes in these categories, preserving the pricing power that comes with innovation-led niches.
Menezes: "For the new products, there will always be a higher-margin idea. So, there is not going to be volume growth. I mean, we are not going to run after volumes over there."
Raw Material and Pricing Dynamics
- RM prices have started to tick up: In the last two weeks, styrene, butyl acrylate, formic acid, and acetic acid prices have risen, though management is uncertain whether this is the start of a trend or a blip.
- HPPC pricing passes through quickly: Price changes in the segment reflect RM moves with a short lag, so any sustained RM uptick would flow into reported revenue relatively fast.
- The company carries no speculative RM book: By avoiding long-term positions, Rossari accepts that it will neither gain nor lose materially from RM timing, keeping the P&L focused on the spread rather than inventory bets.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Consolidated revenue growth | Low double-digit, 12% to 14% | FY24 |
| EBITDA margin | Around 14% | FY24 |
| AHN segment growth | Good growth expected | FY24 |
| Unitop performance | Strong quarter ahead, 2,000+ tonne order book, 85-90%+ utilization | Near term |
| Export recovery | Maintain current run rate for 2 quarters, then grow post textile destocking | H2 FY24 |
| Tristar performance | Good annualized numbers expected | FY24 |
Key Metrics
| Metric | Q1 FY24 |
|---|---|
| Revenue | ₹410.6 cr, compared to ₹406.5 cr in Q4 FY23 and ₹434.7 cr in Q1 FY23 |
| EBITDA | ₹57.7 cr, compared to ₹54.6 cr in Q4 FY23 and ₹57.8 cr in Q1 FY23 |
| EBITDA margin | 14.1%, up 70 bps QoQ and up 80 bps YoY |
| PAT | ₹29.2 cr, compared to ₹29 cr in Q4 FY23 and ₹28.7 cr in Q1 FY23 |
| Consolidated volume growth | ~20% YoY |
| Consolidated revenue growth | -6% YoY |
| HPPC volume growth | 19% YoY |
| Exports | ₹80 cr, roughly 20% of turnover; compared to ₹80 cr in Q4 FY23 and ~₹85 cr in Q1 FY23 |
| Unitop capacity utilization | 85% to 90% plus in the last 3 months including July |
| Unitop pending orders | In excess of 2,000 tonnes |
| Tristar stake acquisition cost | ₹16.9 cr for the remaining 16% stake, taking ownership to 100% |
| FY24 revenue growth guidance | 12% to 14%, management expects to achieve at least this post Q1 performance |
| FY24 EBITDA margin guidance | ~14%, management indicated this would be a good target |